Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Navidea Biopharmaceuticals Inc. logo

Navidea Biopharmaceuticals Inc.

Sector: Healthcare   

Industry: Biotechnology

0.08
 
USD
  
0.00
  
(-2.99%)
Optionable: Yes  Market Cap: 9 M  90-day average vol: 6,417,448

Previous close: 0.0803  Open: 0.088  Bid:   Ask:
52 week range    
0.06   
   0.35
Peers   
GE / 
CNRD / 
LLY / 
INIS / 
ICAD / 
FONR / 
Last updated: Friday 8th December 2023

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

CAH

0.037314 B13.352.63

CNRD

0 B384.815

FONR

0 B9.515.48

GE

0.0032108 B-15.299.9

ICAD

0 B-15.55.32

INIS

0 B11.60.099

LLY

0.0161238 B37.4243.55
Financials

NAVB Income Statement

Annual
Dec-13Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
AccruedPreferredStockDividends46000.0663889.02 M
Amortization-309000.0-94000.040151.0-47590.0
Amortization of intangibles40151.0-47590.0
Basic EPS from continuing operations-1.6-1.8-0.96-0.56
Basic EPS total9.4-1.8-0.96-0.56
Basic weighted shares outstanding6 M7 M8 M8 M8 M9 M14 M24 M29 M31 M
BasicDiscontinuousOperations11.0
Cost of sales-332815.0-2 M-2 M-62260.0-3651.0-96636.06667.01048.01941.0
Depreciation-496178.0-232339.0-120721.0-103165.070393.076954.0-48229.0
Depreciation unreconciled-400000.0-488000.0-571419.0-453549.0-240166.0-150385.0-144512.0-76954.0-95819.0
DepreciationAndAmortization-400000.0-488000.0-571419.0-453549.0-240166.0-150385.0-144512.070393.076954.0-95819.0
Diluted EPS total-2000.0-4.80.2-1.89.0-1.8-0.76-0.96-0.4-0.56
Diluted normalized net income/share-1.8-1.6-1.8-0.76-0.4
Diluted weighted shares outstanding21349.07 M138 M8 M8 M9 M14 M24 M29 M31 M
DilutedDiscontinuousOperations-1.810.6
Earnings from equity interest-523809.0-305253.0-54891.0
EarningsFromEquityInterestNetOfTax-523809.0-305253.0-54891.0
GainOnSaleOfBusiness-614782.02 M
GainOnSaleOfSecurity6000.0-5000.0153357.0846830.011344.0-6361.0
GainsLossOnDisposalOfDiscontinuedOperations758609.0-7 M89 M44502.0-2665.0
GeneralAndAdministrativeExpense-400000.0-357000.0-217000.0-187000.0-139000.0-68000.0-229000.07 M7 M
Gross operating profit797815.05 M11 M5 M2 M1 M624541.0913965.0531513.0-133940.0
Income before tax-43 M-36 M-29 M-7 M-18 M-16 M-11 M-11 M-12 M-15 M
Income restructuring and M&A-557000.0-1 M
Income taxes437426.0-436051.0-204597.0-4 M-9753.0707.020476.016043.0-413252.0
Interest income-112073.0-1 M631208.0
InterestExpenseNonOperating3 M-4 M-7 M-5000.0-159000.0-161000.0-8000.06000.05938.0-344024.0
InterestExpenseOperating-2 M-3 M-5 M-5 M-7 M-8000.0-8000.0-6000.0-9015.0-136432.0
LossAndLossAdjustmentExpectedIncurred1048.0
MinorityInterests855.0648.0210.0379.017.02 M4.03.0
MiscOtherSpecialCharges-1 M-3 M-2 M-27919.0-4 M-5 M30387.0-21854.0351885.0-13294.0
Net income from total operations-43 M-36 M-28 M-14 M77 M-15 M-11 M-11 M-12 M-15 M
NetIncomeCommonStockholders-43 M-36 M-28 M-14 M77 M-15 M-11 M-11 M-12 M-17 M
NetIncomeContinuousOperations-43 M-36 M-28 M-14 M77 M-15 M-11 M-11 M-12 M-15 M
NetIncomeDiscontinuousOperations758609.0-7 M89 M44502.0-2665.0
NetNonOperatingInterestIncomeExpense-3 M-1 M7 M5000.0159000.0-30799.025288.0-6000.0-5938.0-1 M
NetOperatingInterestIncomeExpense-4 M-7 M-4866.0168971.0-30799.0
Normalized income-9 M
Operating income-38 M-28 M-19 M-10 M-14 M-11 M-11 M-11 M-12 M-14 M
Operating income before depreciation (EBITDA)-41 M-41 M-39 M-12 M-25 M-16 M-11 M-11 M-12 M-15 M
OperatingExpense-39 M-32 M-30 M-15 M-16 M-12 M12 M12 M13 M14 M
Other income net1 M3 M3 M-3 M2 M4 M-30387.010510.0-345524.013294.0
OtherGandA-400000.0-357000.0-217000.0-187000.0-139000.0-68000.0-229000.07 M7 M
OtherOperatingExpenses-39 M32 M30 M-15 M-16 M198000.0
OtherunderPreferredStockDividend46000.0663889.02 M
PreferredStockDividends46000.0663889.02 M
RealizedCapitalGain-614782.03 M846830.0
RentAndLandingFees-400000.0-357000.0-217000.0-187000.0-139000.0-68000.0
Research & development expense24 M17 M-13 M7 M5 M4 M5 M5 M5 M6 M
ResearchExpense24 M17 M7 M5 M4 M5 M5 M5 M6 M
RestructringAndMnAIncome-557000.0-1 M
SalariesAndWages-3 M-2 M-2 M-278000.0-394000.0-307000.0-232000.0-301351.0
Selling Gen & administrative expense16 M16 M-17 M8 M11 M8 M6 M7 M7 M8 M
SellingAndMarketingExpense16 M16 M8 M11 M8 M6 M1048.07 M8 M
SellingExpense16 M16 M8 M11 M8 M6 M1048.07 M8 M
Special income/charges557000.01 M
Total Income available for interest expense (EBIT)-42 M-42 M-40 M-13 M-25 M-16 M-11 M-11 M-12 M-16 M
Total common shares outstanding150 M150 M156 M162 M163 M201 M20 M29 M30 M33 M
Total net income-43 M-36 M-28 M-14 M77 M-15 M-11 M-11 M-12 M-15 M
Total ordinary shares100 M100 M100 M100 M100 M100 M100 M100 M100 M100 M
Total revenues1 M6 M13 M5 M2 M1 M631208.0915288.0531513.0-131999.0
TotalExpenses-40 M-34 M-32 M-15 M-16 M-12 M12 M12 M13 M14 M
TotalRevenue614423.04 M10 M39601.02 M1 M631208.0915013.0531513.0-131999.0
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder/CEO of MarketXLS. With over six years of experience, I've helped 2500+ customers implement personalized investment research strategies and monitoring systems in Excel.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.
Get started today